scholarly journals Relationship ofCampylobacterToxigenicity In Vitro to the Development of Postinfectious Irritable Bowel Syndrome

2001 ◽  
Vol 184 (5) ◽  
pp. 606-609 ◽  
Author(s):  
Jonathan P. Thornley ◽  
David Jenkins ◽  
Keith Neal ◽  
Trina Wright ◽  
Jo Brough ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome

In vitro adrenergic and glucocorticoid regulation of cytokine production in postinfectious irritable bowel syndrome

2006 ◽  
Vol 20 (3) ◽  
pp. 44
Author(s):  
Ayscha Lucas ◽  
Pieter Cobelens ◽  
Gerald Holtmann ◽  
Guido Gerken ◽  
Sebastian Haag ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Cytokine Production ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome

scholarly journals Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine

2011 ◽  
Vol 48 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Mauro Bafutto ◽  
José Roberto de Almeida ◽  
Nayle Vilela Leite ◽  
Enio Chaves Oliveira ◽  
Salustiano Gabriel-Neto ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Symptom Score ◽  
Stool Frequency ◽  
Total Symptom Score ◽  
Stool Consistency ◽  
Mucosal Inflammation ◽  
Irritable Bowel Syndrome Group ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome

CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome patients are still unknown. OBJECTIVE: To observe the effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients. METHODS: Based on Rome III criteria, 61 irritable bowel syndrome with diarrhea patients (18 years old or more) were included in the evaluation. Patients were divided into two groups: postinfectious irritable bowel syndrome group, with 18 patients medicated with mesalazine 800 mg 3 times a day for 30 days; noninfective irritable bowel syndrome group, with 43 patients medicated with mesalazine 800 mg 3 times a day for 30 days. Symptom evaluations at baseline and after treatment were performed by means of a four-point Likert scale including stool frequency, stool form and consistency (Bristol Stool Scale), abdominal pain and distension (maximum score: 16; minimum score: 4). RESULTS: Postinfectious irritable bowel syndrome group presented a statistically significant reduction of the total symptom score (P<0.0001). The stool frequency was significantly reduced (P<0.0001), and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distension were significantly reduced (P<0.0001). Noninfective irritable bowel syndrome group presented a statistically significant reduction of total symptom score (P<0.0001). Also, the stool frequency was significantly reduced (P<0.0001) and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distention were significantly reduced (P<0.0001). There was no statistical difference between postinfectious irritable bowel syndrome group and noninfective irritable bowel syndrome group on total symptom score results at 30th day of therapy with mesalazine 800 mg 3 times a day. (P = 0.13). CONCLUSION: Mesalazine reduced key symptoms of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients.

scholarly journals The Impact of Low-Level Iron Supplements on the Faecal Microbiota of Irritable Bowel Syndrome and Healthy Donors Using In Vitro Batch Cultures

Nutrients ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 3819
Author(s):  
Carlos Poveda ◽  
Dora I. A. Pereira ◽  
Marie C. Lewis ◽  
Gemma E. Walton
Keyword(s):  
Irritable Bowel Syndrome ◽  
Gut Microbiota ◽  
Iron Supplementation ◽  
Ferrous Sulphate ◽  
Fluorescence In Situ Hybridisation ◽  
Batch Cultures ◽  
Low Level ◽  
Irritable Bowel ◽  
The Impact

Ferrous iron supplementation has been reported to adversely alter the gut microbiota in infants. To date, the impact of iron on the adult microbiota is limited, particularly at low supplementary concentrations. The aim of this research was to explore the impact of low-level iron supplementation on the gut microbiota of healthy and Irritable Bowel Syndrome (IBS) volunteers. Anaerobic, pH-controlled in vitro batch cultures were inoculated with faeces from healthy or IBS donors along with iron (ferrous sulphate, nanoparticulate iron and pea ferritin (50 μmol−1 iron)). The microbiota were explored by fluorescence in situ hybridisation coupled with flow cytometry. Furthermore, metabolite production was assessed by gas chromatography. IBS volunteers had different starting microbial profiles to healthy controls. The sources of iron did not negatively impact the microbial population, with results of pea ferritin supplementation being similar to nanoparticulate iron, whilst ferrous sulphate led to enhanced Bacteroides spp. The metabolite data suggested no shift to potentially negative proteolysis. The results indicate that low doses of iron from the three sources were not detrimental to the gut microbiota. This is the first time that pea ferritin fermentation has been tested and indicates that low dose supplementation of iron is unlikely to be detrimental to the gut microbiota.

The Clinical Course of Postinfectious Irritable Bowel Syndrome

2009 ◽  
Vol 43 (6) ◽  
pp. 534-540 ◽  
Author(s):  
In Su Jung ◽  
Hee Sun Kim ◽  
Hyojin Park ◽  
Sang In Lee
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Course ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome

Su2031 Postinfectious Irritable Bowel Syndrome and Functional Dyspepsia Following an Outbreak of Tap Water Contamination

2013 ◽  
Vol 144 (5) ◽  
pp. S-536-S-537 ◽  
Author(s):  
Sander van Wanrooij ◽  
Mira M. Wouters ◽  
Stephanie Mondelaers ◽  
Laura van Gerven ◽  
Annick de Vries ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Functional Dyspepsia ◽  
Water Contamination ◽  
Tap Water ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome

Su2047 Fecal and Mucosal Intestinal Microbiota in Postinfectious Irritable Bowel Syndrome (IBS) Patients Differs From General IBS Patients As Well As Healthy Subjects

2015 ◽  
Vol 148 (4) ◽  
pp. S-584
Author(s):  
Johanna Sundin ◽  
Ignacio Rangel ◽  
susana fuentes ◽  
Elisabeth Hultgren Hörnquist ◽  
Willem M. de Vos ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Intestinal Microbiota ◽  
Healthy Subjects ◽  
Irritable Bowel ◽  
Postinfectious Irritable Bowel Syndrome
Sign in / Sign up

Export Citation Format

Share Document